Bicara Therapeutics Inc. (BCAX)

Profile

Full Name

Bicara Therapeutics Inc.

Ticker

NASDAQ: BCAX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 13, 2024

Indexes

Not included

Website

https://www.bicara.com

Employees

55

Key Details

Price

$11.62(-3.01%)

Market cap

$634.02M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$4.05(-100.00% YoY)

PE ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $11.62
    BCAX price is $11.62

    30-Day Relative Volume

    0.59
    BCAX 30-day relative volume is 0.59

    Price Performance

    Price Most recent change

    -3.01%
    BCAX price was down -3.01% on Sep 12, 2025

    Price YTD change

    -33.3%
    BCAX price is down -33.3% since January 1st

    Price 1-year change

    -
    BCAX price 1-year change is unknown

    Price 3-year change

    -
    BCAX price 3-year change is unknown

    Price Range

    Price All-time high

    $28.09
    BCAX price is currently -58.63% below its historical high of $28.09

    Price 3-year low

    $7.80
    BCAX price is currently +48.97% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $634.02M
    BCAX market capitalization is $634.02 million

    Market cap 3-year change

    -
    BCAX market capitalization 3-year change is unknown

    Market cap All-time high

    $1.47B
    BCAX market capitalization is currently -56.93% below its historical high of $1.47 billion

    Market cap sector rank

    66.78%
    BCAX market capitalization is higher than 66.78% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.41%
    BCAX shares outstanding is up +5.41% year-on-year

    Shares Outstanding 3-Year Change

    -
    BCAX shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.54
    BCAX beta is 1.54

    200-day SMA

    $13.01
    BCAX price is currently -10.70% below its 200-day simple moving average

    50-day SMA

    $11.16
    BCAX price is currently +4.09% above its 50-day simple moving average

    RSI

    49.44
    BCAX 14-day relative strength index is 49.44

    Volume

    0.59
    BCAX 30-day relative volume is 0.59

    ATR

    $0.59
    BCAX average true range is $0.59

    10-day Historical Volatility

    30.61%
    BCAX 10-day historical volatility is 30.61%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BCAX annual revenue is $0.00

    Revenue Analysts estimate

    -
    BCAX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    BCAX annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.75%
    BCAX annual revenue is higher than 28.75% of companies in Healthcare sector

    EPS

    EPS

    -$4.05
    BCAX annual earnings per share is -$4.05

    EPS Analysts estimate

    -$2.22
    BCAX annual earnings per share is currently +82.33% higher than the consensus analysts' forecast

    EPS 1-year change

    -100%
    BCAX annual earnings per share is down -100% year-on-year

    EPS Sector rank

    22.64%
    BCAX annual earnings per share is higher than 22.64% of companies in Healthcare sector

    Profit

    Gross profit

    -$56.00K
    BCAX annual gross profit is -$56.00 thousand

    Gross margin

    -
    BCAX annual gross profit margin value is unknown

    Operating profit

    -$82.39M
    BCAX annual operating income is -$82.39 million

    Operating margin

    -
    BCAX annual operating profit margin value is unknown

    Net income

    -$68.00M
    BCAX annual net profit is -$68.00 million

    Net margin

    -
    BCAX annual net profit margin value is unknown

    Expenses

    Total expenses

    $82.39M
    BCAX annual total expenses is $82.39 million

    Operating expenses

    $82.39M
    BCAX annual total operating expenses is $82.39 million

    Cost of goods sold

    $56.00K
    BCAX annual cost of goods sold is $56.00 thousand

    Selling, general & administrative expenses

    $18.77M
    BCAX annual SGA is $18.77 million

    Depreciation and amortization

    $56.00K
    BCAX annual depreciation & amortization is $56.00 thousand

    Interest expense

    $0.00
    BCAX annual interest expense is $0.00

    Income tax

    $187.00K
    BCAX annual income tax is $187.00 thousand

    EBIT & EBITDA

    EBIT

    -$82.39M
    BCAX annual earnings before interest & taxes is -$82.39 million

    EBITDA

    -$82.33M
    BCAX annual EBITDA is -$82.33 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $569.20M
    BCAX annual total assets is $569.20 million

    Non current assets

    $7.46M
    BCAX annual long term assets is $7.46 million

    Current assets

    $502.53M
    BCAX annual total current assets is $502.53 million

    Cash and cash equivalents

    $489.71M
    BCAX annual cash & cash equivalents is $489.71 million

    Accounts receivable

    -
    BCAX annual accounts receivable value is unknown

    Inventory

    $0.00
    BCAX annual inventory is $0.00

    Liabilities

    Total liabilities

    $77.32M
    BCAX annual total liabilities is $77.32 million

    Long term liabilities

    $131.00K
    BCAX annual total long term liabilities is $131.00 thousand

    Current liabilities

    $17.99M
    BCAX annual total current liabilities is $17.99 million

    Accounts payable

    $4.51M
    BCAX annual accounts payable is $4.51 million

    Debt

    Total debt

    $738.00K
    BCAX annual total debt is $738.00 thousand

    Total debt 1-year change

    +12.33%
    BCAX annual total debt is up +12.33% year-on-year

    Long term debt

    $131.00K
    BCAX annual long term debt is $131.00 thousand

    Short term debt

    $607.00K
    BCAX annual short term debt is $607.00 thousand

    Equity & Capital

    Shareholders equity

    $491.88M
    BCAX annual stockholders equity is $491.88 million

    Book value

    $491.88M
    BCAX annual book value is $491.88 million

    Retained earnings

    -$221.02M
    BCAX annual retained earnings is -$221.02 million

    Working capital

    $484.54M
    BCAX annual working capital is $484.54 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$74.75M
    BCAX annual cash flow from operations is -$74.75 million

    Cash from operations 1-year change

    -63.83%
    BCAX annual cash flow from operations is down -63.83% year-on-year

    Cash from investing

    -$9000.00
    BCAX annual cash flow from investing activities is -$9000.00

    Cash from investing 1-year change

    +98.46%
    BCAX annual cash flow from investing activities is up +98.46% year-on-year

    Cash from financing

    $334.03M
    BCAX annual cash flow from financing activities is $334.03 million

    Cash from financing 1-year change

    +22.58%
    BCAX annual cash flow from financing activities is up +22.58% year-on-year

    CAPEX

    CAPEX

    $71.00K
    BCAX annual capital expenditures is $71.00 thousand

    CAPEX 1-year change

    -87.88%
    BCAX annual capital expenditures is down -87.88% year-on-year

    Free Cash Flow

    Free cash flow

    -$74.82M
    BCAX annual free cash flow is -$74.82 million

    Free cash flow 1-year change

    -61.9%
    BCAX annual free cash flow is down -61.9% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BCAX annual gross profit margin value is unknown

    Operating margin

    -
    BCAX annual operating profit margin value is unknown

    Net margin

    -
    BCAX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -16.93%
    BCAX annual return on assets is -16.93%

    ROE

    -19.14%
    BCAX annual return on equity is -19.14%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BCAX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BCAX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.46
    BCAX price to book ratio is 1.46

    PB ratio Sector rank

    44.69%
    BCAX price to book ratio is higher than 44.69% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BCAX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BCAX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $199.65M
    BCAX enterprise value is $199.65 million

    Enterprise value Sector rank

    56.09%
    BCAX enterprise value is higher than 56.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.65
    BCAX EV/EBITDA is -1.65

    EV/EBITDA Sector rank

    39.93%
    BCAX EV/EBITDA is higher than 39.93% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    27.93
    BCAX annual current ratio is 27.93

    Quick ratio

    27.93
    BCAX annual quick ratio is 27.93

    Leverage

    Debt to equity

    0.00
    BCAX annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    BCAX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BCAX piotroski f-score value is unknown

    Altman Z-Score

    4.92
    BCAX altman z-score is 4.92

    Analyst ratings

    Recent major analysts updates

    Aug 22, 25 HC Wainwright & Co.
    Buy
    Aug 19, 25 Piper Sandler
    Overweight
    May 23, 25 Wells Fargo
    Equal-Weight
    May 16, 25 HC Wainwright & Co.
    Buy
    Apr 17, 25 Wells Fargo
    Underweight
    Apr 7, 25 HC Wainwright & Co.
    Buy
    Mar 13, 25 Cantor Fitzgerald
    Overweight
    Feb 12, 25 Wedbush
    Outperform
    Feb 6, 25 Wedbush
    Outperform
    Jan 27, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with BCAX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Bicara Therapeutics Inc.?
    • Does Bicara Therapeutics Inc. pay dividends?
    • What sector is Bicara Therapeutics Inc. in?
    • What industry is Bicara Therapeutics Inc. in?
    • What country is Bicara Therapeutics Inc. based in?
    • When did Bicara Therapeutics Inc. go public?
    • Is Bicara Therapeutics Inc. in the S&P 500?
    • Is Bicara Therapeutics Inc. in the NASDAQ 100?
    • Is Bicara Therapeutics Inc. in the Dow Jones?
    • When was Bicara Therapeutics Inc.'s last earnings report?
    • When does Bicara Therapeutics Inc. report earnings?

    What is the ticker symbol for Bicara Therapeutics Inc.?

    The ticker symbol for Bicara Therapeutics Inc. is NASDAQ:BCAX

    Does Bicara Therapeutics Inc. pay dividends?

    No, Bicara Therapeutics Inc. does not pay dividends

    What sector is Bicara Therapeutics Inc. in?

    Bicara Therapeutics Inc. is in the Healthcare sector

    What industry is Bicara Therapeutics Inc. in?

    Bicara Therapeutics Inc. is in the Biotechnology industry

    What country is Bicara Therapeutics Inc. based in?

    Bicara Therapeutics Inc. is headquartered in United States

    When did Bicara Therapeutics Inc. go public?

    Bicara Therapeutics Inc.'s initial public offering (IPO) was on September 13, 2024

    Is Bicara Therapeutics Inc. in the S&P 500?

    No, Bicara Therapeutics Inc. is not included in the S&P 500 index

    Is Bicara Therapeutics Inc. in the NASDAQ 100?

    No, Bicara Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Bicara Therapeutics Inc. in the Dow Jones?

    No, Bicara Therapeutics Inc. is not included in the Dow Jones index

    When was Bicara Therapeutics Inc.'s last earnings report?

    Bicara Therapeutics Inc.'s most recent earnings report was on August 12, 2025

    When does Bicara Therapeutics Inc. report earnings?

    The next expected earnings date for Bicara Therapeutics Inc. is November 11, 2025
    On this page